A high-stakes feud between U.S. President Donald Trump and Tesla CEO Elon Musk has rattled markets, prompting the White House to step in. According to Politico, aides have scheduled a call between the two on Friday in an attempt to deescalate the situation. The clash, which erupted publicly on Thursday, centers on Musk’s criticism of Trump’s major tax and spending bill, now advancing through Congress.
Tesla (NASDAQ:TSLA) stock plunged over 14% as tensions peaked, with trading data from Robinhood (NASDAQ:HOOD) later showing a partial recovery—up 5% to $298.64 following the report of the upcoming call. Despite this rebound, Tesla remains down about 25% in 2025, with roughly $150 billion wiped off its market capitalization in just hours.
Trump appeared indifferent when questioned by Politico but reportedly instructed aides to tone down his public attacks. However, on social media, the exchange intensified, with Trump threatening to cancel federal contracts for Musk’s companies, including SpaceX. In response, Musk accused Trump of having ties to the late financier Jeffrey Epstein, further fueling the controversy.
Tesla had previously enjoyed political favor under the Trump administration, but the rift now risks regulatory backlash and contract losses. With Musk’s influence in Washington fading, investor sentiment is turning cautious, especially as political uncertainty threatens Tesla’s government-linked ventures.
The unfolding drama between two of the most high-profile figures in business and politics has captivated the public and markets alike. As the scheduled call looms, stakeholders are watching closely to see if the damage can be contained or if deeper repercussions await Tesla’s stock and U.S. tech policy.


Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
New York Legalizes Medical Aid in Dying for Terminally Ill Patients
Trump Signs “America First Arms Transfer Strategy” to Prioritize U.S. Weapons Sales
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Trump Allegedly Sought Airport, Penn Station Renaming in Exchange for Hudson River Tunnel Funding
Jack Lang Resigns as Head of Arab World Institute Amid Epstein Controversy
Norway Opens Corruption Probe Into Former PM and Nobel Committee Chair Thorbjoern Jagland Over Epstein Links
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
U.S.-India Trade Framework Signals Major Shift in Tariffs, Energy, and Supply Chains
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
U.S. Lawmakers to Review Unredacted Jeffrey Epstein DOJ Files Starting Monday
Nighttime Shelling Causes Serious Damage in Russia’s Belgorod Region Near Ukraine Border 



